Drug Database
Back to search

United States· US:25021-179_bd554c4f-8286-4db5-bb82-681d17bd4884

Daptomycin

A daptomycin product containing daptomycin, registered in United States by Sagent Pharmaceuticals. The same ATC class is registered in 17 of our 19 countries.

ATC J01XX09US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDaptomycinATCJ01XX09REGISTER NO.US:25021-179_bd554c4f…PACKS LISTED4CHECKEDAugust 16, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about daptomycinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Daptomycin is registered in 17 of 19 countries.

Countries holding a registration under ATC J01XX09 (daptomycin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search daptomycin products by name

Daptomycin · ATC J01XX09

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of daptomycin costs, country by country.

Normalised to the WHO defined daily dose (0.28 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Daptomycin · price per daily dose (0.28 g)

USD · FX 28 Sept 2026

  • CH Switzerland$88.75
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DAPTOMYCIN
Manufacturer
Sagent Pharmaceuticals
Country
United States (US)
ATC code
J01XX09
ATC class
Daptomycin
Defined daily dose
0.28 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 16, 2026

Packs & prices · 4

  • ndc11
    25021-179-66
  • ndc11
    25021-179-67
  • ndc11
    2502117966
    1 VIAL in 1 CARTON (25021-179-66) / 7 mL in 1 VIAL
  • ndc11
    2502117967
    10 VIAL in 1 CARTON (25021-179-67) / 7 mL in 1 VIAL

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for daptomycin.

Graded by severity as the source publishes them — 18 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check daptomycin against other medicinesHow interaction checks work

Daptomycin · interactions on record

25 records

  • 18 moderate
  • 2 minor

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • IbuprofenC01EB16moderate
  • SimvastatinC10AA01moderate
  • RosuvastatinC10AA07moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Daptomycin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All daptomycin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Daptomycin Accord Healthcare, Daptomycin Accordpharma
  • Belgium · Daptomycine Hikma
  • Bulgaria · Даптомицин Mip
  • Cyprus · Daptomycin Cooper 350mg, Daptomycin Cooper 500mg
  • Czechia · Daptomycin Accordpharma
  • Germany · Daptomycin Accord, Daptomycin Accord Healthcare
  • Denmark · Daptomycin "hameln", Daptomycin Accord Healthcare
  • Estonia · Daptomycin Norameda
  • Spain · Daptomicin Tarbis, Daptomicina Accord
  • Finland · Daptomycin Accord Healthcare, Daptomycin Accordpharma
  • France · Daptomycin Fosun Pharma, Daptomycin Tillomed
  • United Kingdom (Northern Ireland) · Daptomycin, Daptomycin Accord Healthcare
  • Greece · Daptomycin Accord Healthcare, Daptomycin Accordpharma
  • Croatia · Daptomicin Accord Healthcare, Daptomicin Accordpharma
  • Hungary · Daptomycin Anfarm, Daptomycin Hameln
  • Ireland · Daptomycin Accord Healthcare, Daptomycin Accordpharma
  • Iceland · Cubicin, Daptomycin Hameln
  • Italy · Daptomicina Accord, Daptomicina Accordpharma
  • Liechtenstein · Cubicin, Daptomycin Hospira
  • Luxembourg · Daptomycin Eberth, Daptomycine Hikma
  • Malta · Daptomycin Anfarm, Daptomycin Dr. Reddys
  • Netherlands · Daptomicin Accord Healthcare, Daptomicine Accord Healthcare
  • Norway · Cubicin, Daptomycin Accord Healthcare
  • Poland · Daptomicina Fosun Pharma, Daptomycin Accord Healthcare
  • Portugal · Daptomicina Accord Healthcare, Daptomicina Accordpharma
  • Romania · Daptomicină Dr. Reddy’s, Daptomicină Mip
  • Sweden · Daptomycin Accord Healthcare, Daptomycin Accordpharma
  • Slovenia · Daptomicin Accord Healthcare, Daptomicin Accordpharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ea713ec9-0ddb-432a-8707-1bb5a73b592d
GET /v1/drugs/ea713ec9-0ddb-432a-8707-1bb5a73b592d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "350",
  "substance": "DAPTOMYCIN",
  "productndc": "25021-179",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/7mL",
  "application_number": "NDA208385",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about daptomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console